Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroendocrine Response to Oral Alcohol Administration
NCT03165942Phase 1Completed
- Sponsor
- Yale University
- Start
- Sep 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ethanol in alcohol use disorder (AUD), sponsored by Yale University. Primary endpoints: Cerebral Blood Flow at 45 minutes and Change in Amount of drink consumed at 125 minutes. Started Sep 2016; status: completed.
02
Drugs
ethanol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03165942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03165942.